sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has disclosed its position concerning Spire Healthcare Group plc on the 3rd of June, 2026. The disclosure, submitted under Rule 8.3 of the Takeover Code, reveals Vanguard's significant interest in Spire, indicating ownership of 14,482,212 ordinary shares, equating to 3.60% of the company's relevant securities.
The disclosure report confirms there have been recent transactions, specifically the sale of 2,206 shares at a price of 2.17 GBP per share. Currently, there are no cash-settled or stock-settled derivatives associated with this disclosure, emphasizing a straightforward stake in Spire Healthcare Group.
No additional agreements, arrangements, or understandings concerning options or derivatives linking Vanguard to Spire or any other party have been noted, confirming the stand-alone nature of the disclosed interests.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.